Zuogui Pills and Yougui Pills in differential treatment of diminished ovarian reserve based on metabolomics.
10.19540/j.cnki.cjcmm.20230226.502
- Author:
Ying CAO
1
;
Si CHEN
2
;
Yue CHEN
2
;
Ke-da ZHOU
2
;
Pei-Juan WANG
2
;
Qing-Xia SONG
3
Author Information
1. Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine Nanjing 210046, China Suzhou Hospital of Traditional Chinese Medicine Affilated to Nanjing University of Chinese Medicine Suzhou 215009, China.
2. Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine Nanjing 210046, China.
3. Suzhou Hospital of Traditional Chinese Medicine Affilated to Nanjing University of Chinese Medicine Suzhou 215009, China.
- Publication Type:Journal Article
- Keywords:
Yougui Pills;
Zuogui Pills;
diminished ovarian reserve;
kidney-Yang deficiency syndrome;
kidney-Yin deficiency syndrome;
metabolomics
- From:
China Journal of Chinese Materia Medica
2023;48(13):3664-3677
- CountryChina
- Language:Chinese
-
Abstract:
Based on the metabolomics, this paper systematically analyzed the metabolic substance basis of Zuogui Pills and Yougui Pills in syndrome differentiation and treatment of diminished ovarian reserve(DOR), so as to provide a scientific basis for the traditional Chinese medicine(TCM) syndrome differentiation and treatment of DOR. Patients with DOR of kidney-Yin deficiency syndrome were collected from outpatient department of hospitals and treated with Zuogui Pills for 12 weeks. And kidney-Yang deficiency syndrome were treated with Yougui Pills for 12 weeks. Based on the non-targeted metabolomic research techniques, the potential biomarkers of Zuogui Pills and Yougui Pills in the treatment of DOR with kidney-Yin deficiency and kidney-Yang deficiency, respectively, were screened out, and metabolic pathways of biomarkers were analyzed. The pregnancy rate, basic serum hormone levels [basal follicle-stimulating hormone(bFSH), basal-luteinizing hormone(bLH), basal-estradiol(bE_2), and anti-Müllerian hormone(AMH)], TCM syndrome type score, and Kupperman score were recorded and statistically analyzed after treatment. The results showed that 23 patients with DOR of kidney-Yin deficiency syndrome and 25 patients of kidney-Yang deficiency syndrome were collected. Twenty-six differential metabolites, including L-carnitine, acetyl-CoA, coenzyme A, and coenzyme Q_(10)(CoQ10), were mapped to 12 metabolic pathways in patients with kidney-Yin deficiency treated with Zuogui Pills. Twenty-two differential metabolites, such as adipoyl-CoA, L-lysine, lysine arginine, and α-tocopherol, were mapped to 11 metabolic pathways in patients with kidney-Yang deficiency. After treatment, bFSH and bLH of patients with DOR were significantly lower than those before treatment(P<0.05). Although the comparison of bE_2 and AMH had no significant differences, there was a improvement trend. The TCM syndrome type score and Kupperman score of patients with DOR after TCM treatment were significantly lower than those before treatment(P<0.05).
